F. Altmann et al., PROCESSING OF ASPARAGINE-LINKED OLIGOSACCHARIDES IN INSECT CELLS - N-ACETYLGLUCOSAMINYLTRANSFERASE I AND II ACTIVITIES IN CULTURED LEPIDOPTERAN CELLS, Glycobiology, 3(6), 1993, pp. 619-625
The levels of beta 1,2-N-acetylglucosaminyltransferase (GlcNAc-T) I an
d II activities in cultured cells from Bombyx mori (Bm-N), Mamestra br
assicae (IZD-Mb-0503) and Spodoptera frugiperda (Sf-9 and Sf-21) were
investigated. Apart from initial experiments with Man alpha-3(Man alph
a 1-6)-Man beta 1-O(CH2)(8)COOH3 and H-3-labelled UDP-GlcNAc as substr
ates, GlcNAc-T I activity was measured with a nonradioactive HPLC meth
od using pyridylaminated Man(3)-GlcNAc(2) and Man(5)GlcNAc(2) as accep
tor oligosaccharides. It was shown by reversed-phase HPLC, exoglycosid
ase digestion and methylation analysis that the product obtained with
Man(3)GlcNAc(2) contained a terminal GlcNAc residue linked beta 1,2 to
the alpha 1,3 arm of the acceptor. Compared to the enzyme from the hu
man hepatoma cell line HepG2, insect cell GlcNAc-T I exhibited a much
higher preference for the Man(5) substrate. The GlcNAc-T I from Mb-050
3 cells had apparent K-m and V-max values for pyridylaminated Man(3)-
and Man(5)GlcNAc(2) of 2.15 and 0.21 mM, and of 3.4 and 11.4 nmol/h/mg
of cell protein, respectively. When Man(5)GlcNAc(2) was used as the a
cceptor substrate, the levels of GlcNAc-T I activity in the four insec
t cell lines ranged between 7.5 and 14.7 nmol/h/mg of cell protein, an
d thus were comparable to that of HepG2 cells. Evidence is presented f
or the dependence of lepidopteran fucosyltransferase on the presence o
f terminal N-acetylglucosamine. GlcNAc-T II activity could be demonstr
ated by HPLC using GlcNAc beta 1-2Man alpha 1-3(Man alpha 1-6)Man beta
1-4GlcNAc beta 1-4GlcNAc-pyridylamine as the acceptor in the presence
of 6-acetamido-6-deoxycastanospermine as an inhibitor of beta-N-acety
lglucosaminidase. However, the insect cells exhibited specific activit
ies of GlcNAc-T II of only 0.02-0.11 nmol/h/mg of cell protein, much l
ess than HepG2 cells.